| II-31 Sreenath M Krishnan A combined population kinetic-pharmacodynamic-overall survival model for docetaxel and paclitaxel in the treatment of HER2–negative metastatic breast cancer patients Wednesday 15:10-16:40 |
| II-31 Sreenath M Krishnan A combined population kinetic-pharmacodynamic-overall survival model for docetaxel and paclitaxel in the treatment of HER2–negative metastatic breast cancer patients Wednesday 15:10-16:40 |